Kreppner, Wayne,Fogarty, Siobban,Oberegger, Werner,Maes, Paul José Pierre Marie
申请号：
AU2020210227
公开号：
AU2020210227A1
申请日:
2020.07.29
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
#$%^&*AU2020210227A120200820.pdf#####ABSTRACT- 2020210227 A testosterone gel formulation for nasal administration, said testosterone gel formulation comprising: (a) about 4.0% to 8.0% testosterone by weight of said gel formulation； and (b) a pharmaceutically acceptable vehicle. The testosterone gel formulation can further comprise castor oil, oleoyl polyoxylglycerides and colloidal silicon dioxide. The testosterone gel formulation is used for testosterone replacement therapy or to treat hypogonadism or testosterone deficiency.WO 2012/156820 PCT/IB2012/001112 134 130 102 132 100 144 128 140 150 126 122 120 ~T_ 124 FIG. 1 1/22
